 |
|
|
| |
EVALUATING THE EARLY REAL-WORLD IMPACT OF RESMETIROM IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): A UNITED STATES COHORT STUDY USING ELECTRONIC MEDICAL RECORDS
|
| |
| |
AASLD 2025 NOV 7-11 WASH DC
Y. KIM1, J. O'DONNELL1, R. FAKHRAEI2, K. JOHNSTON2, R. SUN2, M. BATHER2, Y. SILBERBERG3, K. KEREN3, R. MUSTAFA2, M. CHARLTON1, R. EISDORFER3, S. BALTER3, R. CHADALAVADA4, N. ALKHOURI5, P. BEKAL4
1. MADRIGAL PHARMACEUTICALS, INC., WEST CONSHOHOCKEN, PA, USA
2. BROADSTREET HEOR, VANCOUVER, BC, CANADA
3. LATICA, PALO ALTO, CA, USA
4. GASTRO HEALTH, CINCINNATI, OH, USA
5. ARIZONA LIVER HEALTH, PHOENIX, AZ, USA
|
| |
|
|
|
|
|
